Literature DB >> 31613139

In situ Analysis of Cancer Cells Based on DNA Signal Amplification and DNA Nanodevices.

Xiaohao Liu1, Sinuo Yu1, Chang Feng1, Dongsheng Mao1, Jinlong Li2, Xiaoli Zhu1.   

Abstract

Cancer is a global disease which has been disturbing researchers in medicine and seriously threatens patients' health and lifetime around the world in the past several decades. Due to the characteristics of cancer cells, such as uncontrollable cell proliferation, cell invasion and metastasis to surrounding tissues, lower grade of differentiation, higher telomerase activity and others, it has been one of the most usual lethal factors, next to heart disease in incidence. Cancer mortality can be decreased by early diagnosis, and the people who with treatment at an early stage have an obvious improved survival rate. Consequently, early detection is significant for better understanding the pathogenesis of cancer and improving the prognosis of patients. In situ detection technique is a vital tool for imaging and cellular pathology research, which can provide effective information about tumor markers in the early cancer detection. In view of low expression of most tumor markers in the early stage of cancers, detection techniques based on DNA signal amplification and DNA nanodevices can provide a strong support for the diagnosis and detection of cancers. In this review, we summarize the research progress of different analytical techniques for detecting various tumor markers that have been reported in recent years. We compare different DNA amplification and nanodevices, then provide guidance and suggestions for better understanding in situ analysis of cancer cells.

Entities:  

Keywords:  Amplification; DNA nanodevices; cancer; detection; tumor markers

Mesh:

Substances:

Year:  2019        PMID: 31613139     DOI: 10.1080/10408347.2019.1674631

Source DB:  PubMed          Journal:  Crit Rev Anal Chem        ISSN: 1040-8347            Impact factor:   6.535


  3 in total

1.  [Pan-cancer analysis of the expression pattern of long non-coding RNA MIR22HG].

Authors:  H Wang; W Li; D Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-04-20

Review 2.  Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.

Authors:  Yingkun Xu; Meiying Shen; Yang Peng; Li Liu; Lingfeng Tang; Ting Yang; Dongyao Pu; Wenhao Tan; Wenjie Zhang; Shengchun Liu
Journal:  Biomed Res Int       Date:  2022-08-30       Impact factor: 3.246

3.  Nondestructive analysis of tumor-associated membrane protein MUC1 in living cells based on dual-terminal amplification of a DNA ternary complex.

Authors:  Xiaohao Liu; Dongsheng Mao; Guoli Deng; Yuchen Song; Fan Zhang; Shiqi Yang; Genxi Li; Feng Liu; Wei Cao; Xiaoli Zhu
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.